Home Search
COVID-19 - search results
If you're not happy with the results, please do another search
Will increased COVID-19 testing keep children in schools?
Abdullah Sabyah, Founder and CEO Rightangled, discusses the need to overhaul the government’s approach to coronavirus testing in schools and explores how home-based private testing can ensure children continue to receive the education they need.
EU Pharma Strategy: COVID-19 shows the need for diverse supply chains
Rex Clements, CEO at Centrient Pharmaceuticals, discusses how the upcoming EU Pharma Strategy can prevent shortages and strengthen Europe’s manufacturing base, especially for antibiotics.
First whole city COVID-19 testing to launch in Liverpool
In the first pilot of whole city testing, residents and workers in Liverpool will be offered COVID-19 testing, whether they have symptoms or not.
COVID-19 and Africa’s volatile changing epidemics landscape
Here, SACIDS Foundation for One Health discuss the volatile changing epidemics landscape in Africa.
What is the cost of COVID-19 in the UK?
The total financial cost of COVID-19 won’t be known until after the crisis is over - but we can look into the available data and piece something together.
Republicans more likely to follow COVID-19 guidelines for themselves
New research from the UBC Sauder School of Business suggests that Republicans are more likely to follow COVID-19 guidelines to protect themselves rather than for their community.
Black communities to receive COVID-19 information via new app
A cardiologist from the University of Cincinnati is partnering with researchers in St. Louis and rural Georgia to develop a smartphone app that will deliver COVID-19 information and education to Black communities.
Research finds 96,000 new COVID-19 infections daily in the UK
Imperial College London found that the R number is now at 1.6, which means that new COVID-19 infections are steadily increasing.
£4 million data project to accelerate COVID-19 treatment
The new £4 million research project, CO-CONNECT, will help scientists access data to help develop potential treatments for COVID-19.
Have COVID-19 school closures impacted academic achievement?
The American Education Research Association discusses initial insights onto how COVID-19 school closures in Spring 2020 impacted student learning.
Long haul COVID-19 survivors experience lasting skin problems
According to a new analysis, COVID-19 patients have shown lasting skin problems long after their initial infection has cleared.
Commission launches additional measures to limit the spread of COVID-19
The European Commission is launching an additional set of actions to help limit the spread of the coronavirus and save lives.
New £8m funding supports UK-India COVID-19 research collaboration
UK Research and Innovation (UKRI) and the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India are launching a joint funding initiative to support the UK-India COVID-19 research collaboration.
When is the UK COVID-19 vaccine going to be ready?
While AstraZeneca and Oxford University continue to work on a UK COVID-19 vaccine, what about the rest of the world?
Study finds antibody response to COVID-19 reduces over time
The largest at-home antibody study for COVID-19 has found that the number of people with antibodies fell by 26.5% after infection.
New research explores the mutation of COVID-19
Researchers at the University of Illinois investigated how the mutation of COVID-19 is making the virus stronger.
COVID-19 in New York: The outbreak came from atleast 109 sources
Researchers have investigated the origins of COVID-19 in New York - from the sources that started the infection, to how it spread through the population.
Research finds hydroxychloroquine does not work against COVID-19
A study published in Clinical Infectious Diseases found that hydroxychloroquine did not work to protect healthcare professionals from COVID-19.
Researchers given £2.3m to investigate the neurological impacts of COVID-19
Researchers from the University of Liverpool and King’s College London have received a £2.3 million fund from UK Research and Innovation (UKRI) to investigate the neurological impacts of COVID-19.
The ‘herd immunity’ strategy for COVID-19 is dangerous and unfeasible
Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.